Antares Therapeutics
PrivateLast Round
Corporate Funding
Jun 24, 2026
Total Funding Raised
$177M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Antares Therapeutics is a biotechnology company that develops first-in-class precision medicines targeting previously undruggable proteins in oncology and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antares Therapeutics Comparables
Compare Antares Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frontier Medicines | 87% | |
| Nimbus Therapeutics | 83% | |
| Belharra Therapeutics | 83% | |
Antares Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jun 24, 2026 | ||||
| Series A | Jun 10, 2025 |
Antares Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series A |
| Cormorant Asset Management | Series A |
| Vida Ventures | Series A |
| Abingworth | Series A |
| BVF Partners L.P. | Series A |
| Atlas Venture | Series A |
| Willett Advisors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 57% MoM.
- Jun 24, 2026
Monthly visitors grew 51% MoM, from 2.2K to 3.3K.
Antares Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antares Therapeutics's valuation, stock price, and market status.